HLSE:ORNBVPharmaceuticals
What Orion Oyj (HLSE:ORNBV)'s New Innovative Medicines Leadership Structure Means For Shareholders
Orion Corporation has appointed Berkeley Vincent as Executive Vice President, Innovative Medicines and Executive Team member as of 8 April 2026, splitting the previously combined R&D and Innovative Medicines leadership role into two focused positions.
This leadership change highlights Orion’s intent to sharpen its global commercialization focus for Innovative Medicines by bringing in a veteran Johnson & Johnson executive with extensive launch, market access and partnership experience.
Next,...